Post
Generics expected to improve access for patients with idiopathic pulmonary fibrosis
The idiopathic pulmonary fibrosis (IPF) market is underserved with just two licensed pharmaceutical treatments that are available globally, Roche’s Esbriet/Pirespa …
Mobile health strategies: Should you build or partner for success?
As the digital transformation of healthcare continues to gather pace, the explosion of digital health solutions is hard to ignore. …
UKHSA signs influenza vaccine deal with CSL Seqirus
The UK Health Security Agency (UKHSA) has signed an advance purchase agreement with healthcare company CSL Seqirus for influenza pandemic …
Arcturus Therapeutics extends cystic fibrosis treatment deal
Arcturus Therapeutics has extended an existing agreement with the Cystic Fibrosis (CF) Foundation for advancing ARCT-032. ARCT-032 is an investigational messenger …
MilliporeSigma opens two new mRNA manufacturing facilities in Germany
Merck’s Life Science business MilliporeSigma has opened two new messenger ribonucleic acid (mRNA) drug substance manufacturing facilities in Germany. Developed with …
UKHSA signs influenza vaccine deal with CSL Seqirus
The UK Health Security Agency (UKHSA) has signed an advance purchase agreement with healthcare company CSL Seqirus for influenza pandemic …
Arcturus Therapeutics extends cystic fibrosis treatment deal
Arcturus Therapeutics has extended an existing agreement with the Cystic Fibrosis (CF) Foundation for advancing ARCT-032. ARCT-032 is an investigational messenger …
MilliporeSigma opens two new mRNA manufacturing facilities in Germany
Merck’s Life Science business MilliporeSigma has opened two new messenger ribonucleic acid (mRNA) drug substance manufacturing facilities in Germany. Developed with …
Alfasigma to buy Intercept Pharmaceuticals for $794m
Italian company Alfasigma has signed a definitive agreement for the acquisition of all issued and outstanding shares in Intercept Pharmaceuticals in a …
Acesion wins €45m in Series B funding to develop atrial fibrillation therapy
Danish biotech Acesion Pharma has raised €45m in an oversubscribed Series B financing round. The money will go towards funding …
Coherus Biosciences gets hit with CRL for pegfilgrastim biosimilar injectable
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) to Coherus, setting back the company’s plans …
Sandoz scores European approval for Tysabri biosimilar
Sandoz has received approval from the European Commission (EC) for marketing Tyruko (natalizumab), a biosimilar version of Biogen’s Tysabri, in …
Signal: Big Pharma embraces AI as Novo Nordisk partners with AI start-up Valo in $2.7bn deal
Danish pharmaceutical company Novo Nordisk and US medtech start-up, Valo, have partnered to use Valo’s AI-powered human dataset to discover …
The competitive edge: Unlocking the full potential of autoinjectors through comprehensive in-house manufacturing
The drug delivery device industry has experienced exponential growth and innovation in the past three decades, driven by the rising …
GSK receives Japanese approval of RSV vaccine for older patients
GSK has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Arexvy (respiratory syncytial virus vaccine, recombinant …